Omega Healthcare Investors, Inc.
OHI · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.47 | -0.72 | 5.44 | 0.11 |
| FCF Yield | 7.67% | 8.38% | 8.76% | 8.94% |
| EV / EBITDA | 14.88 | 14.80 | 11.57 | 12.33 |
| Quality | ||||
| ROIC | 6.24% | 5.40% | 4.27% | 5.99% |
| Gross Margin | 98.62% | 98.42% | 98.24% | 98.85% |
| Cash Conversion Ratio | 1.79 | 2.48 | 1.43 | 1.69 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.18% | -3.68% | -0.53% | 4.59% |
| Free Cash Flow Growth | 21.32% | 6.78% | -7.74% | -0.96% |
| Safety | ||||
| Net Debt / EBITDA | 4.56 | 5.70 | 4.98 | 5.27 |
| Interest Coverage | 3.02 | 2.08 | 1.68 | 2.41 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 705.41 | 662.19 | 607.84 | 542.25 |